
44th Annual UCLA State-of-the-Art Urology Conference
The Ritz-Carlton
Marina del Rey, California
March 08, 2019 to March 10, 2019
*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.
Syllabus for Conference Registrants
Download: [ PDF ]
This course explores the most challenging management problems facing the practicing urologist. Distinguished faculty present current information and techniques in female pelvic medicine and reconstruction, stress urinary incontinence, nocturia, renal and ureteral stones, surgical therapies and technologies for BPH, diet and supplements for men’s health, pelvic and scrotal pain, testosterone replacement therapy, urologic oncology (prostate, bladder, kidney), imaging (Fluciclovine Scan and PSMA PET) and ablative therapies, biomarkers for cancer detection and management, prostate MRI, active surveillance, robotic surgery pearls, BCG unresponsive bladder cancer, management of the small renal mass, GU dermatology and practice management. The conference emphasizes interaction between participants and faculty and allows ample time for case presentations and group discussions, ensuring an outstanding educational experience for attendees.
Enrollment
Enrollment is limited. Early enrollment is advised.
To enroll click here.
By Mail
Send the completed enrollment form to:
David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
UCLA State-of-the-Art Urology
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512
By Fax
Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.
By Phone
Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620
Course Fees
- $550 Physicians
- $350 David Geffen School of Medicine at UCLA Faculty
- $275 Non-Physicians, Healthcare Professionals
- $110 Residents (accompanied by a confirmatory letter of status from department chief or training director)
Refunds
Cancellations must be received in writing by February 1, 2019, and will be subject to a $75 processing fee. No refunds will be given after that date. If, for any reason, the course must be canceled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided. You may fax your refund request to 310-794-2624.
Course Chair
William J. Aronson, MD
Course Co-Chairs
Craig Canfield, MD
Karim Chamie, MD, MSHS
Guest Faculty
Steven A. Kaplan, MD
Professor of Urology
Icahn School of Medicine at Mount Sinai
Director, The Men’s Health Program
Mount Sinai Health System
New York, New York
Laurence Klotz, MD, CM
Professor of Surgery, University of Toronto
Sunnybrook Chair of Prostate Cancer Research
Division of Urology
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Vandana “Wendy” Madkan, MD, FAAD
Mosaic Dermatology of Santa Monica & Beverly Hills
Beverly Hills, California
James M. McKiernan, MD
John K. Lattimer Professor and Chairman
Department of Urology
Columbia University Vagelos College of Physicians & Surgeons
New York-Presbyterian Hospital
New York, New York
Mark A. Moyad, MD, MPH
Jenkins/Pokempner Director of Complementary and Alternative Medicine
Department of Urology
University of Michigan Medical Center
Ann Arbor, Michigan
Mark N. Painter, BA, CPMA
CEO
PRS, LLC
Thornton, Colorado
Marshall L. Stoller, MD
Professor
Department of Urology
University of California, San Francisco
San Francisco, California
J. Christian Winters, MD, FACS
Vice Chancellor of Clinical Affairs & CEO of LSU Healthcare Network
H. Eustis Reily Professor and Chairman, Department of Urology
LSU Health Sciences Center
New Orleans, Louisiana
Evan Y. Yu, MD
Professor, Division of Oncology, Department of Medicine
University of Washington School of Medicine
Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington
Department of Urology Faculty*
Mark S. Litwin, MD, MPH
Professor and Chair
Department of Urology
Professor of Health Policy and Management
School of Public Health
William J. Aronson, MD
Z. Chad Baxter, MD
Karim Chamie, MD, MSHS
Arnold I. Chin, MD, PhD
Matthew Dunn, MD
Ja-Hong Kim, MD
Steven E. Lerman, MD
Leonard S. Marks, MD
Jesse N. Mills, MD
Gladys Ng, MD
Victor W. Nitti, MD
Allan J. Pantuck, MD, MS
Nishant D. Patel, MD
Jacob Rajfer, MD
Robert E. Reiter, MD, MBA
Christopher S. Saigal, MD, MPH
Brian Shuch, MD
Jennifer S. Singer, MD
Renea Sturm, MD
UCLA Faculty*
Alexandra Drakaki, MD, PhD
Assistant Professor of Medicine and Urology
Director - Genitourinary Medical Oncology Program
Co-Director of Research, GU Trials Program
Division of Hematology/Oncology
and Institute of Urologic Oncology
Amar U. Kishan, MD
Assistant Professor
Department of Radiation Oncology
Sandy T. Liu, MD
Division of Hematology-Oncology, Department of Medicine
Institute of Urologic Oncology, Department of Urology
Steven S. Raman, MD
Professor of Radiology, Surgery and Urology
Department of Radiology
Karol E. Watson, MD, PhD
Professor of Medicine/Cardiology
Co-Director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program
*David Geffen School of Medicine at UCLA
Friday, March 8, 2019 |
|
Morning | |
7:00 | Registration / Breakfast / Exhibits |
7:50 |
Introductions and Announcements William J. Aronson, MD |
Male and Female Voiding Dysfunction, Reconstruction, Surgical Tips and Tricks Moderator: Victor W. Nitti, MD |
|
8:00 |
Female LUTS Workup - What’s Necessary, What’s Not Victor W. Nitti, MD |
8:20 |
Urodynamics - What’s Important, Technical Considerations J. Christian Winters, MD, FACS |
8:40 |
Surgical Treatment of Stress Urinary Incontinence - State of the Art Victor W. Nitti, MD |
9:00 |
Nocturia - A Practical Approach Steven A. Kaplan, MD |
9:20 | Break / Exhibits |
9:40 |
Biology of Pelvic Pain - Practical Use of Non-Opioid Alternatives J. Christian Winters, MD, FACS |
10:00 |
Does Medical Therapy for BPH Make Sense Anymore Steven A. Kaplan, MD |
10:20 |
New Technologies for Vaginal Health Victor W. Nitti, MD |
10:40 |
New Technologies for BPH Steven A. Kaplan, MD |
11:00 |
Panel Discussion and Case Presentations Moderator: Dr. Victor Nitti Panel: Drs. Baxter, Kaplan, Kim and Winters |
12:00 | Lunch |
Afternoon | |
Urolithiasis Moderator: Matthew Dunn, MD |
|
1:00 |
ESWL Strategies in 2019 Matthew Dunn, MD |
1:15 |
Tips and Tricks for Endoscopic Management of Urinary Stones Marshall L. Stoller, MD |
1:35 |
The Mini-Perc - Indications, Technical Aspects Matthew Dunn, MD |
1:50 |
Practical Metabolic Workup for Stone Disease Marshall L. Stoller, MD |
2:05 |
Panel Discussion and Case Presentations Moderator: Dr. Matthew Dunn Panel: Drs. Patel and Stoller |
3:00 | Break / Exhibits |
GU Dermatology Moderator: William J. Aronson, MD |
|
3:20 |
Genitourinary Dermatology - Diagnosis and Management Pearls Vandana Madkan, MD, FAAD |
Men’s Health Moderator: Jacob Rajfer, MD |
|
3:50 |
Testosterone Deficiency and Management: AUA 2018 Guidelines Update Christopher S. Saigal, MD, MPH |
4:10 |
Algorithmic Approach to Scrotal and Post-Vasectomy Pain Jesse N. Mills, MD |
4:30 |
Diet and Supplements for Prostate and Sexual Health - Fact or Fiction Mark A. Moyad, MD, MPH |
5:00 |
Panel Discussion and Case Presentations Moderator: Dr. Jacob Rajfer Panel: Drs. Mills, Moyad, and Saigal |
5:45 | Adjourn and Reception |
Saturday, March 9th, 2019 |
|
Morning | |
6:30 | Breakfast / Exhibits |
Video Session | |
7:00 |
High Risk Disease, Integration of Imaging with Surgical Management Technical Aspects: T3 Disease, Salvage Lymphadenectomy Robert E. Reiter, MD, MBA |
7:30 |
Challenges in Robotic Radical Prostatectomy Nerve Sparing, The Very Large Prostate Robert E. Reiter, MD, MBA |
Prostate Cancer Moderator: Mark S. Litwin, MD, MPH |
|
8:00 |
Diagnosis: Contemporary Imaging, Biomarkers, and Biopsy Strategies Laurence Klotz, MD, CM |
8:20 |
Focal Therapy in 2019 - What’s Approved Now and What’s Next Leonard S. Marks, MD |
8:35 |
Active Surveillance in 2019 - State of the Art Laurence Klotz, MD, CM |
8:55 |
Update on Short Course Radiation Therapy: Safety and Efficacy Amar U. Kishan, MD |
9:05 |
Panel Discussion and Case Presentations Moderator: Dr. Mark Litwin Panel: Drs. Kishan, Klotz, Marks, Reiter and Yu |
10:00 | Break / Exhibits |
10:20 |
Molecular Imaging For Staging and Advanced Disease - Axumin and PSMA Robert E. Reiter, MD, MBA |
10:35 |
Late Breaking News - Treatment of Oligometastatic Disease Evan Y. Yu, MD |
10:45 |
Reducing Morbidity and Improving Survival in Men on ADT Laurence Klotz, MD, CM |
11:00 |
Pragmatic Sequencing Therapy for Castrate Resistant Prostate Cancer Evan Y. Yu, MD |
11:20 |
Panel Discussion and Case Presentations Moderator: Dr. Mark Litwin Panel: Drs. Kishan, Klotz, Marks, Reiter and Yu |
12:00 | Lunch |
Afternoon | |
Bladder Cancer Moderator: Mark S. Litwin, MD, MPH |
|
1:05 |
BCG Unresponsive NMIBC - What To Do Next Effective Chemotherapy Options - When to Refer for Blue Light James McKiernan, MD |
1:20 |
Recurrent Low Grade Bladder Cancer Karim Chamie, MD, MSHS |
1:30 |
BCG Complications and Management James M. McKiernan, MD |
1:45 |
Making the Immune System Work for the Urologist Evan Y. Yu, MD |
2:00 |
Panel Discussion and Case Presentations Moderator: Dr. Mark Litwin Panel: Drs. Chamie, Chin, Drakaki, Kishan, McKiernan and Yu |
2:50 | Break / Exhibits |
Kidney Cancer Moderator: Karim Chamie, MD, MSHS |
|
3:10 |
Focal Therapy Case Study - 65 yo with 3 cm Renal Mass and Renal Insufficiency Steven S. Raman, MD Active Surveillance Brian Shuch, MD Partial Nephrectomy James M. McKiernan, MD |
3:40 |
Cytoreductive Nephrectomy: Where Do We Stand Today James M. McKiernan, MD |
3:55 |
Panel Discussion and Case Presentations Moderator: Dr. Chamie Panel: Drs. Liu, McKiernan, Pantuck, Raman and Shuch |
5:30 | Adjourn |
Sunday, March 10, 2019 |
|
Morning | |
6:30 | Breakfast / Exhibits |
Video Session | |
7:00 |
Robotic Partial Nephrectomy Pearls Karim Chamie, MD, MSHS |
7:30 |
BPH - Endourology Pearls Matthew Dunn, MD |
Practice Management Moderator: Christopher S. Saigal, MD, MPH |
|
8:00 |
Practice Management
|
10:00 | Break / Exhibits |
Selected Topics of Interest Moderator: William J. Aronson, MD |
|
10:20 |
Cardiac Health - What the Urologist Needs to Know Karol E. Watson, MD, PhD |
10:50 |
Urologic Management of Transgender Patients Gladys Ng, MD |
Moderator: Steven E. Lerman, MD | |
11:10 |
What’s New in Pediatric Urology Steven E. Lerman, MD |
11:35 |
Pediatric Urology Panel Discussion and Case Presentations Moderator: Steven E. Lerman, MD Panel: Drs. Singer and Sturm |
12:30 | Adjourn |
At the completion of this program, participants should be better able to:
- Utilize biomarkers and biopsy techniques for prostate cancer detection and active surveillance
- Determine the role for prostate MRI prior to the first prostate biopsy
- Determine the role for SBRT for prostate cancer
- Understand the present and future role for fluciclovine scan and PSMA imaging
- Manage advanced prostate cancer
- Understand the present role for focal therapy for prostate cancer
- Utilize alternative intravesical chemotherapies for bladder cancer
- Manage the small renal mass
- Manage GU pelvic pain conditions
- Treat male and female voiding dysfunction, BPH, nocturia, and kidney stones
- Counsel patients on the role of diet and supplements in men’s health
- Treat testosterone deficiency
- Manage GU dermatologic conditions
- Navigate coding and related practice management issues
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 22 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
American Society of Radiologic Technologists Credit
Approved by the ASRT for a maximum of 15.75 Category A continuing education credit.
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.
The Department of Urology is a California Board of Nursing approved provider (#8888).
Location
The Ritz-Carlton, Marina del Rey
4375 Admiralty Way
Marina del Rey, California 90292
310-823-1700 or 800-241-3333
310-823-2404 facsimile
www.ritzcarlton.com/hotels/marina_del_rey
Accommodations
A block of rooms has been reserved at the Ritz-Carlton for conference participants at a special conference rate of $309.00 plus tax per night for single/double occupancy. One night’s deposit is required to guarantee late arrival (after 5 pm). Confirmation of reservations received after February 5, 2019 is subject to availability.
For reservations call 310-823-1700 or 800-241-3333.
Be sure to mention UCLA’s State-of-the-Art Urology Conference when calling in your reservations. You may also visit their website: https://book.passkey.com/go/UrologyConference2019.
Parking
Daytime: $13 valet only
Overnight: $28
Transportation to Hotel from LAX
Taxi or shuttle service is available from Los Angeles International Airport to the Ritz-Carlton, Marina del Rey.